Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Interest Coverage Ratio (2018 - 2023)

Rapid Therapeutic Science Laboratories' Interest Coverage Ratio history spans 6 years, with the latest figure at 1.71 for Q2 2023.

  • For Q2 2023, Interest Coverage Ratio fell 916.96% year-over-year to 1.71; the TTM value through Jun 2023 reached 0.93, down 26.97%, while the annual FY2022 figure was 0.67, 59.45% up from the prior year.
  • Interest Coverage Ratio for Q2 2023 was 1.71 at Rapid Therapeutic Science Laboratories, down from 0.89 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.39 in Q4 2022 and bottomed at 160.95 in Q2 2021.
  • The 5-year median for Interest Coverage Ratio is 1.11 (2022), against an average of 17.86.
  • The largest annual shift saw Interest Coverage Ratio crashed 4727.8% in 2020 before it surged 140.07% in 2022.
  • A 5-year view of Interest Coverage Ratio shows it stood at 4.07 in 2019, then plummeted by 647.01% to 30.43 in 2020, then soared by 96.82% to 0.97 in 2021, then soared by 140.07% to 0.39 in 2022, then crashed by 540.16% to 1.71 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Interest Coverage Ratio are 1.71 (Q2 2023), 0.89 (Q1 2023), and 0.39 (Q4 2022).